| Ident. | Authors (with country if any) | Title |
|---|
| 000B97 (2003) |
Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa ; Sadako Kuno ; Mitsutoshi Yamamoto ; Kazuko Hasegawa ; Hideki Origasa ; Hisayuki Kowa | Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. |
| 001119 (2005) |
Yasuyuki Okuma [Japon] ; Kenji Fujishima ; Hideto Miwa ; Hideo Mori ; Yoshikuni Mizuno | Myoclonic tremulous movements in multiple system atrophy are a form of cortical myoclonus. |
| 001307 (2005) |
Satoshi Orimo [Japon] ; Takeshi Amino ; Masayuki Yokochi ; Tohru Kojo ; Toshiki Uchihara ; Atsushi Takahashi ; Koichi Wakabayashi ; Hitoshi Takahashi ; Nobutaka Hattori ; Yoshikuni Mizuno | Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. |
| 001635 (2006) |
Shin-Ichiro Kubo [Japon] ; Nobutaka Hattori ; Yoshikuni Mizuno | Recessive Parkinson's disease. |
| 001642 (2006) |
Hiroyuki Tomiyama [Japon] ; Yuanzhe Li ; Manabu Funayama ; Kazuko Hasegawa ; Hiroyo Yoshino ; Shin-Ichiro Kubo ; Kenichi Sato ; Tatsuya Hattori ; Chin-Song Lu ; Rivka Inzelberg ; Ruth Djaldetti ; Eldad Melamed ; Rim Amouri ; Neziha Gouider-Khouja ; Faycal Hentati ; Yasuko Hatano ; Mei Wang ; Yoko Imamichi ; Koichi Mizoguchi ; Hiroaki Miyajima ; Fumiya Obata ; Tatsushi Toda ; Matthew J. Farrer ; Yoshikuni Mizuno ; Nobutaka Hattori | Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries. |
| 001733 (2006) |
Kenichi Sato [Japon] ; Taku Hatano ; Kazuo Yamashiro ; Maki Kagohashi ; Kenya Nishioka ; Nana Izawa ; Hideki Mochizuki ; Nobutaka Hattori ; Hideo Mori ; Yoshikuni Mizuno | Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations. |
| 001953 (2007) |
Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa ; Sadako Kuno ; Nobuo Yanagisawa ; Mitsutoshi Yamamoto ; Tomoyoshi Kondo | Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients. |
| 001D65 (2007) |
Yoshikuni Mizuno [Japon] ; Takashi Abe ; Kazuko Hasegawa ; Sadako Kuno ; Tomoyoshi Kondo ; Mitsutoshi Yamamoto ; Mitsuyoshi Nakashima ; Ichiro Kanazawa | Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. |
| 001F87 (2007) |
Bruno Dubois [France] ; David Burn ; Christopher Goetz ; Dag Aarsland ; Richard G. Brown ; Gerald A. Broe ; Dennis Dickson ; Charles Duyckaerts ; Jefferey Cummings ; Serge Gauthier ; Amos Korczyn ; Andrew Lees ; Richard Levy ; Irene Litvan ; Yoshikuni Mizuno ; Ian G. Mckeith ; C Warren Olanow ; Werner Poewe [Autriche] ; Cristina Sampaio ; Eduardo Tolosa ; Murat Emre | Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. |
| 002101 (2008) |
Kazuo Yamashiro [Japon] ; Miki Komine-Kobayashi ; Taku Hatano ; Takao Urabe ; Hideki Mochizuki ; Nobutaka Hattori ; Yoshitaka Iwama ; Hiroyuki Daida ; Michi Sakai ; Takeo Nakayama ; Yoshikuni Mizuno | The frequency of cardiac valvular regurgitation in Parkinson's disease. |
| 002164 (2008) |
Manabu Funayama [Japon] ; Yuanzhe Li ; Tak-Hong Tsoi ; Ching-Wan Lam ; Takekazu Ohi ; Shogo Yazawa ; Eiichiro Uyama ; Ruth Djaldetti ; Eldad Melamed ; Hiroyo Yoshino ; Yoko Imamichi ; Hiroshi Takashima ; Kenya Nishioka ; Kenichi Sato ; Hiroyuki Tomiyama ; Shin-Ichiro Kubo ; Yoshikuni Mizuno ; Nobutaka Hattori | Familial Parkinsonism with digenic parkin and PINK1 mutations. |
| 002287 (2008) |
Hiroyuki Tomiyama [Japon] ; Yasumasa Kokubo ; Ryogen Sasaki ; Yuanzhe Li ; Yoko Imamichi ; Manabu Funayama ; Yoshikuni Mizuno ; Nobutaka Hattori ; Shigeki Kuzuhara | Mutation analyses in amyotrophic lateral sclerosis/parkinsonism-dementia complex of the Kii peninsula, Japan. |
| 002743 (2009) |
Kenya Nishioka [Japon] ; Owen A. Ross ; Kenji Ishii ; Jennifer M. Kachergus ; Kiichi Ishiwata ; Mayumi Kitagawa ; Satoshi Kono ; Tomokazu Obi ; Koichi Mizoguchi ; Yuichi Inoue ; Hisamasa Imai ; Masashi Takanashi ; Yoshikuni Mizuno ; Matthew J. Farrer ; Nobutaka Hattori | Expanding the clinical phenotype of SNCA duplication carriers. |
| 002B95 (2010) |
Anthony H V. Schapira [Royaume-Uni] ; Stefan Albrecht ; Paolo Barone ; Cynthia L. Comella ; Michael P. Mcdermott ; Yoshikuni Mizuno ; Werner Poewe [Autriche] ; Olivier Rascol ; Kenneth Marek | Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study. |
| 002C74 (2010) |
Yoshikuni Mizuno [Japon] ; Kazuko Hasegawa ; Tomoyoshi Kondo ; Sadako Kuno ; Mitsutoshi Yamamoto | Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study. |
| 002D22 (2010) |
Olivier Rascol [France] ; Paolo Barone ; Robert A. Hauser ; Yoshikuni Mizuno ; Werner Poewe [Autriche] ; Anthony H V. Schapira ; Laurence Salin ; Mandy Sohr ; Catherine Debieuvre | Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. |
| 002D60 (2010) |
Robert A. Hauser [États-Unis] ; Anthony H V. Schapira ; Olivier Rascol ; Paolo Barone ; Yoshikuni Mizuno ; Laurence Salin ; Monika Haaksma ; Nolwenn Juhel ; Werner Poewe [Autriche] | Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. |
| 002F28 (2010) |
Manabu Funayama [Japon] ; Hiroyuki Tomiyama ; Ruey-Meei Wu ; Kotaro Ogaki ; Hiroyo Yoshino ; Yoshikuni Mizuno ; Nobutaka Hattori | Rapid screening of ATP13A2 variant with high-resolution melting analysis. |
| 003255 (2011) |
Thomas Gasser [Allemagne] ; John Hardy ; Yoshikuni Mizuno | Milestones in PD genetics. |
| 003A28 (2013) |
Saori Miyakawa [Japon] ; Mieko Ogino ; Sayaka Funabe ; Akiko Uchino ; Yasushi Shimo ; Nobutaka Hattori ; Masaaki Ichinoe ; Tetuo Mikami ; Makoto Saegusa ; Kazutoshi Nishiyama ; Hideo Mori ; Yoshikuni Mizuno ; Shigeo Murayama ; Hideki Mochizuki | Lewy body pathology in a patient with a homozygous parkin deletion. |
| 003A87 (2013) |
Yoshikuni Mizuno [Japon] ; Tomoyoshi Kondo [Japon] | Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease |
